Respiratory Tract Diseases

568 trials 207 recruiting

Filter these 568 trials by phase, country and sponsor.

Open in Search →

Use of MULTIplex PCR, procalcitonin and the appearance of sputum to reduce the duration of antibiotic therapy during severe COPD EXAcerbatio… Recruiting

2024-511896-13-00 EA-COPD (with mechanical ventilation, invasive or non-i 11 2022-12-09
A phase IIa, randomized, placebo-controlled, double-blind, cross-over study to evaluate safety and efficacy of subcutaneous administration o… Recruiting

2023-510376-31-00 Cystic fibrosis 4 2022-10-05
ASPIC - Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care Recruiting

2024-513327-16-00 Intensive care 5 2022-09-20
Efficacy, Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With… Recruiting

2024-511382-11-00 Asthma 4 2022-08-29
Inhalation therapy in adult bronchiectasis patients with new asymptomatic Pseudomonas aeruginosa infection– an open-label, proof of concept … Recruiting

2023-509277-22-00 Bronchiectasis 4 2022-06-22
Sotorasib in advanced KRAS G12C-mutated non-small cell lung cancer patients with comorbidities (SOLUCOM) Recruiting

2023-503174-20-00 KRAS G12C-mutated non-small cell lung cancer 4 2022-05-30
A Prospective, Open-label, Platform Study for Long-term Follow-up of Participants Using Study Intervention in Pulmonary Hypertension Parent … Recruiting

2023-506791-27-00 pulmonary arterial hypertension 5 2022-04-22
A randomised controlled trial in preterm infants comparing prophylactic with selective “Less Invasive Surfactant Administration” (pro.LISA) Recruiting

2024-516504-42-00 Respiratory distress syndrome in preterm infants 5 2022-03-05
Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age: RhinoPOC RCT Recruiting

2024-512561-13-00 Rhinovirus-induced Wheezing 6 2022-02-11
Predictive Signature of Benralizumab Response. BENRAPRED Study. Recruiting

2024-514843-27-00 Severe asthma 6 2021-10-11
Short Treatment With Omalizumab for Severe Asthma (SHORTEN) Recruiting

2024-513427-17-00 Well controlled severe allergic asthma 6 2021-05-20
Phase II trial exploring combined neoadjuvant therapy with Pembrolizumab/Lenvatinib and adjuvant Pembrolizumab in patients with surgically r… Recruiting

2024-514821-45-00 Non-Small-Cell Lung Cancer 4 2021-05-12
Phase 2 Study of Adagrasib Monotherapy and in Combination With Pembrolizumab and Phase 3 Study of Adagrasib in Combination with Pembrolizuma… Recruiting

2023-508922-83-00 Advanced Non-Small Cell Lung Cancer 10 2021-03-17
Cyclophosphamide and Azathioprine vs Tacrolimus in antisynthetase syndrome-related interstitial lung disease: multicentric randomized phase … Recruiting

2024-511868-83-00 Antisynthetase syndrome-related interstitial lung disea 5 2021-02-05
The SANT-study - A randomized controlled clinical trial of Streptococcus group A-negative acute tonsillitis in primary health care - a compa… Recruiting

2023-508542-18-00 Tonsilitis 6 2019-09-02
Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing - The INSTAR study Recruiting

2024-515350-25-01 Acute wheezing/bronchiolitis 6 2019-04-12
TRAUMADORNASE A Prospective, Randomized Multicenter, Double Blind Clinical Trial Comparing Inhaled Dornase Alfa and Its Placebo to Reduce th… Recruiting

2024-512034-14-00 severe trauma 5 2019-03-04
The Norwegian Antibiotics for Pneumonia in Children (NAPIC) Study Recruiting

2024-512001-39-01 Lower respiratory tract infection 6 2018-02-01
Parenteral Retinol Level and Tolerability Trial Ended

2024-516994-59-00 Bronchopulmonary Dysplasia 4 2026-02-13
Long-term safety and efficacy evaluation of lunsekimig in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP) who comp… Ended

2024-515912-27-00 Chronic rhinosinusitis with nasal polyps 4 2025-12-08
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants with Severe Asthma Ended

2024-519469-23-00 Severe Asthma 4 2025-10-20
Study of zoldonrasib in Previously Treated Patients with RAS G12D-Mutant Non-Small Cell Lung Cancer (NSCLC) Ended

2025-521681-10-00 Lung Cancer 4 2025-10-02
Studying the LAIV induced Immune respOnse in the Nasopharynx of young children. Ended

2024-513933-18-00 Influenza 6 2025-09-18
Study to assess whether Verekitug can improve the control of Chronic Obstructive Pulmonary Disease (COPD) Ended

2025-520488-42-00 Moderate-to-Severe Chronic Obstructive Pulmonary Diseas 4 2025-09-17